Answers are grounded in this paper and cite their sources.
Evaluation of: van Rossum CT, Pijl H, Adan RA, Hoebee B, Seidell JC: Polymorphisms in the NPY and AGRP genes and body fatness in Dutch adults. Int. J. Obes. (Lond.). 30, 1522–1528 (2006). Neuropeptide Y (NPY) is one of the most potent orexigenic neuropeptides in the hypothalamus, a key brain area for energy-balance regulation. In addition, agouti-related protein (AGRP), an antagonist of the anorexigenic melanocortin system, is evidently involved in energy homeostasis. This longitudinal population-based study of young adults in The Netherlands puts further light on the potential involvement of the relatively rare NPY Leu7Pro and AGRP Ala67Thr polymorphisms in the variation of body fatness. Those with stable weight over 8 years, and those with weight gain, were analyzed separately. Male carriers of the NPY Pro7 allele had an increased body mass index and leptin level, which is consistent with previous reports. However, male carriers of the AGRP Thr67 allele had an increased body mass index, which is less consistent with previous reports. These, and previous findings on the impact of NPY Leu7Pro and AGRP Ala67Pro on body fatness regulation, should be investigated further in larger cohorts.
No takes yet. Share an insight, caveat, or question.
Catharina Lavebratt (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: